Donaldson Capital Management LLC Raises Position in UnitedHealth Group Incorporated (NYSE:UNH)

Donaldson Capital Management LLC increased its holdings in UnitedHealth Group Incorporated (NYSE:UNH) by 11.1% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 103,909 shares of the healthcare conglomerate’s stock after buying an additional 10,390 shares during the period. UnitedHealth Group accounts for 2.5% of Donaldson Capital Management LLC’s investment portfolio, making the stock its 15th biggest position. Donaldson Capital Management LLC’s holdings in UnitedHealth Group were worth $54,705,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds also recently bought and sold shares of UNH. Robbins Farley bought a new stake in shares of UnitedHealth Group during the 3rd quarter worth $25,000. Richelieu Gestion SA bought a new stake in shares of UnitedHealth Group during the 4th quarter worth $26,000. CGC Financial Services LLC lifted its holdings in shares of UnitedHealth Group by 1,000.0% during the 4th quarter. CGC Financial Services LLC now owns 55 shares of the healthcare conglomerate’s stock worth $29,000 after acquiring an additional 50 shares during the last quarter. NewSquare Capital LLC lifted its holdings in shares of UnitedHealth Group by 340.0% during the 3rd quarter. NewSquare Capital LLC now owns 66 shares of the healthcare conglomerate’s stock worth $33,000 after acquiring an additional 51 shares during the last quarter. Finally, LFA Lugano Financial Advisors SA lifted its holdings in shares of UnitedHealth Group by 148.1% during the 4th quarter. LFA Lugano Financial Advisors SA now owns 67 shares of the healthcare conglomerate’s stock worth $35,000 after acquiring an additional 40 shares during the last quarter. 87.86% of the stock is owned by institutional investors.

UnitedHealth Group Stock Up 1.5 %

Shares of NYSE UNH traded up $6.43 during midday trading on Monday, hitting $445.63. The stock had a trading volume of 5,369,294 shares, compared to its average volume of 4,304,947. The business’s 50 day moving average is $492.29 and its 200-day moving average is $516.34. The company has a market cap of $410.84 billion, a P/E ratio of 18.74, a PEG ratio of 1.20 and a beta of 0.54. UnitedHealth Group Incorporated has a 52 week low of $436.38 and a 52 week high of $554.70. The company has a quick ratio of 0.79, a current ratio of 0.79 and a debt-to-equity ratio of 0.62.

UnitedHealth Group (NYSE:UNH) last released its quarterly earnings data on Friday, January 12th. The healthcare conglomerate reported $6.16 earnings per share for the quarter, beating the consensus estimate of $5.98 by $0.18. UnitedHealth Group had a net margin of 6.02% and a return on equity of 26.39%. The firm had revenue of $94.43 billion during the quarter, compared to analysts’ expectations of $92.13 billion. During the same period in the previous year, the company earned $5.34 earnings per share. The firm’s quarterly revenue was up 14.1% on a year-over-year basis. As a group, analysts predict that UnitedHealth Group Incorporated will post 27.7 EPS for the current year.

UnitedHealth Group Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Tuesday, March 19th. Shareholders of record on Monday, March 11th were issued a dividend of $1.88 per share. The ex-dividend date was Friday, March 8th. This represents a $7.52 dividend on an annualized basis and a yield of 1.69%. UnitedHealth Group’s dividend payout ratio is currently 31.54%.

Insider Buying and Selling at UnitedHealth Group

In other UnitedHealth Group news, CAO Thomas E. Roos sold 858 shares of the company’s stock in a transaction that occurred on Friday, February 23rd. The shares were sold at an average price of $525.79, for a total transaction of $451,127.82. Following the completion of the sale, the chief accounting officer now directly owns 32,289 shares of the company’s stock, valued at $16,977,233.31. The sale was disclosed in a filing with the SEC, which can be accessed through this link. In other news, CAO Thomas E. Roos sold 858 shares of the stock in a transaction on Friday, February 23rd. The shares were sold at an average price of $525.79, for a total value of $451,127.82. Following the completion of the sale, the chief accounting officer now directly owns 32,289 shares of the company’s stock, valued at $16,977,233.31. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, EVP Erin Mcsweeney sold 1,236 shares of the stock in a transaction on Friday, March 8th. The stock was sold at an average price of $483.48, for a total transaction of $597,581.28. Following the completion of the sale, the executive vice president now directly owns 9,364 shares of the company’s stock, valued at $4,527,306.72. The disclosure for this sale can be found here. 0.35% of the stock is owned by corporate insiders.

Analysts Set New Price Targets

A number of equities analysts recently commented on UNH shares. Morgan Stanley decreased their target price on shares of UnitedHealth Group from $618.00 to $584.00 and set an “overweight” rating on the stock in a research report on Friday, April 5th. Erste Group Bank restated a “hold” rating on shares of UnitedHealth Group in a research report on Wednesday, March 13th. Bank of America restated a “buy” rating and issued a $675.00 price objective on shares of UnitedHealth Group in a research report on Thursday, March 7th. TD Cowen decreased their price objective on shares of UnitedHealth Group from $607.00 to $546.00 and set a “buy” rating on the stock in a research report on Wednesday, April 10th. Finally, Piper Sandler cut their target price on shares of UnitedHealth Group from $584.00 to $581.00 and set an “overweight” rating on the stock in a research note on Wednesday, January 17th. Three investment analysts have rated the stock with a hold rating and sixteen have assigned a buy rating to the company’s stock. According to MarketBeat.com, UnitedHealth Group presently has an average rating of “Moderate Buy” and an average target price of $573.80.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.